Mark Kleiman recently wrote a great post on morality in drug policy:   Jonathan Rauch, who heads the Brookings side of the project, found that line of argument troubling. He asked me whether the interests of the responsible 80% should really have to yield to the interests of the irresponsible 20%. (Since the two … Continue reading Rights, morality and drug policy